Cargando…

Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: The delay study

Survival rates for patients with idiopathic pulmonary arterial hypertension (IPAH) have improved with the introduction of PAH-specific therapies. However, the time between patient-reported onset of symptoms and a definitive diagnosis of IPAH is consistently delayed. We conducted a retrospective, mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strange, Geoff, Gabbay, Eli, Kermeen, Fiona, Williams, Trevor, Carrington, Melinda, Stewart, Simon, Keogh, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641745/ https://www.ncbi.nlm.nih.gov/pubmed/23662179 http://dx.doi.org/10.4103/2045-8932.109919

Ejemplares similares

Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?
por: Steele, Peter, et al.
Publicado: (2010)

Integrated care and optimal management of pulmonary arterial hypertension
por: Strange, Geoff, et al.
Publicado: (2009)

Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort
por: Strange, Geoff, et al.
Publicado: (2012)

Exercise Intolerance in Pulmonary Arterial Hypertension
por: Fowler, Robin M., et al.
Publicado: (2012)

Review of bosentan in the management of pulmonary arterial hypertension
por: Gabbay, Eli, et al.
Publicado: (2007)

Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes
por: Ratwatte, Seshika, et al.
Publicado: (2023)

Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan
por: Tynan, Timothy, et al.
Publicado: (2019)

RETRACTED: Right to left ventricular volume ratio: A novel marker of disease severity in chronic thromboembolic pulmonary hypertension()
por: Jaijee, Shareen, et al.
Publicado: (2013)

Chronic Thromboembolic Pulmonary Hypertension: Treat the Patient Not the Haemodynamics
por: Dunne, Ben, et al.
Publicado: (2012)

Australian perspective regarding recommendations for physical activity and exercise rehabilitation in pulmonary arterial hypertension
por: Fowler, Robin, et al.
Publicado: (2011)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Is It Still “Idiopathic”? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension
por: Frech, Tracy M., et al.
Publicado: (2022)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Epistatic interactions in idiopathic pulmonary arterial hypertension
por: Vadapalli, Shivani, et al.
Publicado: (2012)

Pulmonary hypertension in remote and disadvantaged population: overcoming unique challenges for improved outcomes
por: Naing, Pyi, et al.
Publicado: (2022)

An Australian tertiary referral center experience of the management of chronic thromboembolic pulmonary hypertension
por: Maliyasena, Videshinie A., et al.
Publicado: (2012)

Haemodynamic definitions and updated clinical classification of pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2019)

Definition and Management of Segmental Pulmonary Hypertension
por: Dimopoulos, Konstantinos, et al.
Publicado: (2018)

Updated definition of exercise pulmonary hypertension
por: Zeder, Katarina, et al.
Publicado: (2022)

Prevalence and survival associated with pulmonary hypertension after mitral valve replacement: National echocardiography database of Australia study
por: Collins, Nicholas, et al.
Publicado: (2022)

Upregulated Genes In Sporadic, Idiopathic Pulmonary Arterial Hypertension
por: Edgar, Alasdair J, et al.
Publicado: (2006)

Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension
por: Khirfan, Ghaleb, et al.
Publicado: (2018)

Nocturnal hypoxia in patients with idiopathic pulmonary arterial hypertension
por: Yan, Lu, et al.
Publicado: (2020)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
por: Rosenzweig, Erika B., et al.
Publicado: (2019)

Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia
por: Anderson, James J., et al.
Publicado: (2022)

Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”
por: Matura, Lea Ann, et al.
Publicado: (2022)

Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension
por: Twiss, James, et al.
Publicado: (2013)

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension
por: Li, Yuan, et al.
Publicado: (2022)

Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension
por: van der Have, Oscar, et al.
Publicado: (2023)

Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial
por: Ganderton, Louise, et al.
Publicado: (2011)

Risk Factors for Hemoptysis in Idiopathic and Hereditary Pulmonary Arterial Hypertension
por: Tio, Darryl, et al.
Publicado: (2013)

The mystery of persistent pulmonary hypertension: an idiopathic infantile arterial calcification
por: Shaireen, Huma, et al.
Publicado: (2013)

Hoarseness of voice as presenting complaint of idiopathic pulmonary arterial hypertension
por: Garg, Rajiv, et al.
Publicado: (2017)

Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension
por: Jones, Rowena J., et al.
Publicado: (2022)

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension
por: Zhang, Rui, et al.
Publicado: (2020)

Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
por: Heukels, Peter, et al.
Publicado: (2021)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
por: Hoeper, Marius M, et al.
Publicado: (2022)

Growing up with Idiopathic Pulmonary Arterial Hypertension: An Arduous Journey
por: Dutilleux, Tanguy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aodek9httk70r66a03t18dubfs